Greatbatch to Redeem Convertible Subordinated Debentures


Greatbatch to Redeem Convertible Subordinated Debentures

FRISCO, Texas--(BUSINESS WIRE)-- Greatbatch, Inc. (NYS: GB) , today announced it is electing to redeem all of its outstanding 2¼% Convertible Subordinated Debentures due 2013. The aggregate principal amount of Debentures to be redeemed is $197,796,000. The CUSIP numbers of the Debentures being redeemed are 972232-AB-8 and 39153L-AB-2.

The date fixed for redemption is February 20, 2013. The redemption price at which the Debentures are to be redeemed is 100% of the principal amount of the Debentures. The place of payment will be made upon presentation and surrender of the Debentures is Manufacturers and Traders Trust Company, Corporate Trust Administration, One M&T Plaza, 7th Floor, Buffalo, NY 14203.

About Greatbatch, Inc.

Greatbatch, Inc. (NYS: GB) provides top-quality technologies to industries that depend on reliable, long-lasting performance through its brands Greatbatch Medical, Electrochem and QiG Group. Greatbatch Medical develops and manufactures critical medical device technologies for the cardiac, neurology, vascular and orthopaedic markets. Electrochem designs and manufactures custom battery technologies for high end niche applications in the portable medical, energy, military and other markets. The QiG Group empowers the design and development of new medical devices for the company's core markets. Additional information about Greatbatch is available at


Greatbatch, Inc.
Christopher Knospe, 716-759-5727
Marco Benedetti, 716-759-5856

KEYWORDS: United States North America New York Texas


The article Greatbatch to Redeem Convertible Subordinated Debentures originally appeared on

Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Copyright © 1995 - 2012 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

Originally published